Mutation analysis of LRP10 in a large Chinese familial Parkinson disease cohort
Copyright © 2020 Elsevier Inc. All rights reserved..
Recently, LRP10 has been identified as a causative gene for Parkinson's disease (PD). However, subsequent studies showed inconsistent conclusions. To explore its relevance to PD, we systematically analyzed LRP10 rare mutations in a large Han Chinese familial PD cohort of 385 unrelated probands using segregation analysis, transcriptional effect analysis, and burden test. As a result, 3 missense variants and 1 splicing region variant in LRP10 were identified in 4 probands. Segregation analysis revealed 1 variant p.Arg66His cosegregating with PD status, 1 variant p.Ala613Ser not, and the other variant p.Gln581His unknown. The variant c.406+5G>T located at the splicing region has no effect on splicing, suggesting it is likely a rare neutral intronic variant. The burden test suggested no significant over-representation of rare variants in PD probands. Therefore, more robust independent studies are warranted to explore the pathogenicity of LRP10 mutations.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:99 |
---|---|
Enthalten in: |
Neurobiology of aging - 99(2021) vom: 16. März, Seite 99.e1-99.e6 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Li, ChunYu [VerfasserIn] |
---|
Links: |
---|
Themen: |
Genetics |
---|
Anmerkungen: |
Date Completed 28.09.2021 Date Revised 07.12.2022 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.neurobiolaging.2020.08.015 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM315216433 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM315216433 | ||
003 | DE-627 | ||
005 | 20231225154429.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.neurobiolaging.2020.08.015 |2 doi | |
028 | 5 | 2 | |a pubmed24n1050.xml |
035 | |a (DE-627)NLM315216433 | ||
035 | |a (NLM)32950273 | ||
035 | |a (PII)S0197-4580(20)30271-2 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Li, ChunYu |e verfasserin |4 aut | |
245 | 1 | 0 | |a Mutation analysis of LRP10 in a large Chinese familial Parkinson disease cohort |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 28.09.2021 | ||
500 | |a Date Revised 07.12.2022 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2020 Elsevier Inc. All rights reserved. | ||
520 | |a Recently, LRP10 has been identified as a causative gene for Parkinson's disease (PD). However, subsequent studies showed inconsistent conclusions. To explore its relevance to PD, we systematically analyzed LRP10 rare mutations in a large Han Chinese familial PD cohort of 385 unrelated probands using segregation analysis, transcriptional effect analysis, and burden test. As a result, 3 missense variants and 1 splicing region variant in LRP10 were identified in 4 probands. Segregation analysis revealed 1 variant p.Arg66His cosegregating with PD status, 1 variant p.Ala613Ser not, and the other variant p.Gln581His unknown. The variant c.406+5G>T located at the splicing region has no effect on splicing, suggesting it is likely a rare neutral intronic variant. The burden test suggested no significant over-representation of rare variants in PD probands. Therefore, more robust independent studies are warranted to explore the pathogenicity of LRP10 mutations | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a Genetics | |
650 | 4 | |a LRP10 | |
650 | 4 | |a Mutation | |
650 | 4 | |a Parkinson’s disease | |
650 | 7 | |a LDL-Receptor Related Proteins |2 NLM | |
650 | 7 | |a LRP10 protein, human |2 NLM | |
700 | 1 | |a Chen, YongPing |e verfasserin |4 aut | |
700 | 1 | |a Ou, RuWei |e verfasserin |4 aut | |
700 | 1 | |a Gu, XiaoJing |e verfasserin |4 aut | |
700 | 1 | |a Wei, QianQian |e verfasserin |4 aut | |
700 | 1 | |a Cao, Bei |e verfasserin |4 aut | |
700 | 1 | |a Zhang, LingYu |e verfasserin |4 aut | |
700 | 1 | |a Hou, YanBing |e verfasserin |4 aut | |
700 | 1 | |a Liu, KunCheng |e verfasserin |4 aut | |
700 | 1 | |a Chen, XuePing |e verfasserin |4 aut | |
700 | 1 | |a Song, Wei |e verfasserin |4 aut | |
700 | 1 | |a Zhao, Bi |e verfasserin |4 aut | |
700 | 1 | |a Wu, Ying |e verfasserin |4 aut | |
700 | 1 | |a Shang, HuiFang |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Neurobiology of aging |d 1980 |g 99(2021) vom: 16. März, Seite 99.e1-99.e6 |w (DE-627)NLM012615501 |x 1558-1497 |7 nnns |
773 | 1 | 8 | |g volume:99 |g year:2021 |g day:16 |g month:03 |g pages:99.e1-99.e6 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.neurobiolaging.2020.08.015 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 99 |j 2021 |b 16 |c 03 |h 99.e1-99.e6 |